Proposed primary endpoints for use in clinical trials that compare treatment options for bloodstream infection in adults: a consensus definition.
Identifieur interne : 000753 ( PubMed/Curation ); précédent : 000752; suivant : 000754Proposed primary endpoints for use in clinical trials that compare treatment options for bloodstream infection in adults: a consensus definition.
Auteurs : P N A. Harris [Australie] ; J F Mcnamara [Australie] ; D C Lye [Singapour] ; J S Davis [Australie] ; L. Bernard [France] ; A C Cheng [Australie] ; Y. Doi [États-Unis] ; V G Fowler [États-Unis] ; K S Kaye [États-Unis] ; L. Leibovici [Israël] ; J. Lipman [Afrique du Sud] ; M J Llewelyn [Royaume-Uni] ; S. Munoz-Price [États-Unis] ; M. Paul [Israël] ; A Y Peleg [Australie] ; J. Rodríguez-Ba O [Espagne] ; B A Rogers [Australie] ; H. Seifert [Allemagne] ; V. Thamlikitkul [Thaïlande] ; G. Thwaites [Royaume-Uni] ; S Y C. Tong [Australie] ; J. Turnidge [Australie] ; R. Utili [Italie] ; S A R. Webb [Australie] ; D L Paterson [Australie]Source :
- Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [ 1469-0691 ] ; 2017.
Abstract
To define standardized endpoints to aid the design of trials that compare antibiotic therapies for bloodstream infections (BSI).
DOI: 10.1016/j.cmi.2016.10.023
PubMed: 27810466
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000756
Links to Exploration step
pubmed:27810466Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Proposed primary endpoints for use in clinical trials that compare treatment options for bloodstream infection in adults: a consensus definition.</title><author><name sortKey="Harris, P N A" sort="Harris, P N A" uniqKey="Harris P" first="P N A" last="Harris">P N A. Harris</name><affiliation wicri:level="1"><nlm:affiliation>University of Queensland, UQ Centre for Clinical Research, Brisbane, Qld, Australia; Department of Microbiology, Pathology Queensland, Central Laboratory, Royal Brisbane & Women's Hospital, Brisbane, Qld, Australia. Electronic address: p.harris@uq.edu.au.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>University of Queensland, UQ Centre for Clinical Research, Brisbane, Qld, Australia; Department of Microbiology, Pathology Queensland, Central Laboratory, Royal Brisbane & Women's Hospital, Brisbane, Qld</wicri:regionArea></affiliation></author><author><name sortKey="Mcnamara, J F" sort="Mcnamara, J F" uniqKey="Mcnamara J" first="J F" last="Mcnamara">J F Mcnamara</name><affiliation wicri:level="1"><nlm:affiliation>University of Queensland, UQ Centre for Clinical Research, Brisbane, Qld, Australia; Department of Microbiology, Pathology Queensland, Central Laboratory, Royal Brisbane & Women's Hospital, Brisbane, Qld, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>University of Queensland, UQ Centre for Clinical Research, Brisbane, Qld, Australia; Department of Microbiology, Pathology Queensland, Central Laboratory, Royal Brisbane & Women's Hospital, Brisbane, Qld</wicri:regionArea></affiliation></author><author><name sortKey="Lye, D C" sort="Lye, D C" uniqKey="Lye D" first="D C" last="Lye">D C Lye</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Infectious Disease and Epidemiology, Tan Tock Seng Hospital and Yong Loo Lin School of Medicine, Singapore.</nlm:affiliation><country xml:lang="fr">Singapour</country><wicri:regionArea>Institute of Infectious Disease and Epidemiology, Tan Tock Seng Hospital and Yong Loo Lin School of Medicine</wicri:regionArea></affiliation></author><author><name sortKey="Davis, J S" sort="Davis, J S" uniqKey="Davis J" first="J S" last="Davis">J S Davis</name><affiliation wicri:level="1"><nlm:affiliation>Global and Tropical Health Division, Menzies School of Health Research, Darwin, NT, Australia; Department of Infectious Diseases, John Hunter Hospital, Newcastle, NSW, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Global and Tropical Health Division, Menzies School of Health Research, Darwin, NT, Australia; Department of Infectious Diseases, John Hunter Hospital, Newcastle, NSW</wicri:regionArea></affiliation></author><author><name sortKey="Bernard, L" sort="Bernard, L" uniqKey="Bernard L" first="L" last="Bernard">L. Bernard</name><affiliation wicri:level="1"><nlm:affiliation>Infectious Diseases Unit, Tours University Hospital, Tours, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Infectious Diseases Unit, Tours University Hospital, Tours</wicri:regionArea></affiliation></author><author><name sortKey="Cheng, A C" sort="Cheng, A C" uniqKey="Cheng A" first="A C" last="Cheng">A C Cheng</name><affiliation wicri:level="1"><nlm:affiliation>Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Vic., Australia; Department of Infectious Diseases, The Alfred Hospital and Central Clinical School, Monash University, Melbourne, Vic., Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Vic., Australia; Department of Infectious Diseases, The Alfred Hospital and Central Clinical School, Monash University, Melbourne, Vic.</wicri:regionArea></affiliation></author><author><name sortKey="Doi, Y" sort="Doi, Y" uniqKey="Doi Y" first="Y" last="Doi">Y. Doi</name><affiliation wicri:level="1"><nlm:affiliation>Division of Infectious Diseases, University of Pittsburgh School of Medicine, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Infectious Diseases, University of Pittsburgh School of Medicine, PA</wicri:regionArea></affiliation></author><author><name sortKey="Fowler, V G" sort="Fowler, V G" uniqKey="Fowler V" first="V G" last="Fowler">V G Fowler</name><affiliation wicri:level="1"><nlm:affiliation>Duke University Medical Center and Duke Clinical Research Institute, Durham, NC, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Duke University Medical Center and Duke Clinical Research Institute, Durham, NC</wicri:regionArea></affiliation></author><author><name sortKey="Kaye, K S" sort="Kaye, K S" uniqKey="Kaye K" first="K S" last="Kaye">K S Kaye</name><affiliation wicri:level="1"><nlm:affiliation>Wayne State University School of Medicine, Detroit Medical Center, Detroit, MI, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Wayne State University School of Medicine, Detroit Medical Center, Detroit, MI</wicri:regionArea></affiliation></author><author><name sortKey="Leibovici, L" sort="Leibovici, L" uniqKey="Leibovici L" first="L" last="Leibovici">L. Leibovici</name><affiliation wicri:level="1"><nlm:affiliation>Department of Medicine E, Beilinson Hospital, Rabin Medical Center, Petah-Tiqva, Israel; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.</nlm:affiliation><country xml:lang="fr">Israël</country><wicri:regionArea>Department of Medicine E, Beilinson Hospital, Rabin Medical Center, Petah-Tiqva, Israel; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv</wicri:regionArea></affiliation></author><author><name sortKey="Lipman, J" sort="Lipman, J" uniqKey="Lipman J" first="J" last="Lipman">J. Lipman</name><affiliation wicri:level="1"><nlm:affiliation>Burns, Trauma and Critical Care Research Centre, The University of Queensland, Brisbane, Qld, Australia; Department of Intensive Care Medicine, Royal Brisbane and Women's Hospital, Brisbane, Qld, Australia; The University of Witwatersrand, Johannesburg, South Africa.</nlm:affiliation><country xml:lang="fr">Afrique du Sud</country><wicri:regionArea>Burns, Trauma and Critical Care Research Centre, The University of Queensland, Brisbane, Qld, Australia; Department of Intensive Care Medicine, Royal Brisbane and Women's Hospital, Brisbane, Qld, Australia; The University of Witwatersrand, Johannesburg</wicri:regionArea></affiliation></author><author><name sortKey="Llewelyn, M J" sort="Llewelyn, M J" uniqKey="Llewelyn M" first="M J" last="Llewelyn">M J Llewelyn</name><affiliation wicri:level="1"><nlm:affiliation>Division of Medicine, Brighton and Sussex Medical School, Brighton, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Division of Medicine, Brighton and Sussex Medical School, Brighton</wicri:regionArea></affiliation></author><author><name sortKey="Munoz Price, S" sort="Munoz Price, S" uniqKey="Munoz Price S" first="S" last="Munoz-Price">S. Munoz-Price</name><affiliation wicri:level="1"><nlm:affiliation>Froedtert & Medical College of Wisconsin, Milwaukee, WI, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Froedtert & Medical College of Wisconsin, Milwaukee, WI</wicri:regionArea></affiliation></author><author><name sortKey="Paul, M" sort="Paul, M" uniqKey="Paul M" first="M" last="Paul">M. Paul</name><affiliation wicri:level="1"><nlm:affiliation>Division of Infectious Diseases, Rambam Health Care Campus and The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel.</nlm:affiliation><country xml:lang="fr">Israël</country><wicri:regionArea>Division of Infectious Diseases, Rambam Health Care Campus and The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa</wicri:regionArea></affiliation></author><author><name sortKey="Peleg, A Y" sort="Peleg, A Y" uniqKey="Peleg A" first="A Y" last="Peleg">A Y Peleg</name><affiliation wicri:level="1"><nlm:affiliation>Department of Microbiology, Monash University, Melbourne, Vic., Australia; School of Clinical Sciences, Monash Medical Centre, Monash University, and Monash Infectious Diseases, Monash Health, Clayton, Vic., Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Department of Microbiology, Monash University, Melbourne, Vic., Australia; School of Clinical Sciences, Monash Medical Centre, Monash University, and Monash Infectious Diseases, Monash Health, Clayton, Vic.</wicri:regionArea></affiliation></author><author><name sortKey="Rodriguez Ba O, J" sort="Rodriguez Ba O, J" uniqKey="Rodriguez Ba O J" first="J" last="Rodríguez-Ba O">J. Rodríguez-Ba O</name><affiliation wicri:level="1"><nlm:affiliation>Unidad Clínica Intercentros de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospitales Universitarios Virgen Macarena y Virgen del Rocío-IBiS and Departamento de Medicina, Universidad de Sevilla, Seville, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Unidad Clínica Intercentros de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospitales Universitarios Virgen Macarena y Virgen del Rocío-IBiS and Departamento de Medicina, Universidad de Sevilla, Seville</wicri:regionArea></affiliation></author><author><name sortKey="Rogers, B A" sort="Rogers, B A" uniqKey="Rogers B" first="B A" last="Rogers">B A Rogers</name><affiliation wicri:level="1"><nlm:affiliation>School of Clinical Sciences, Monash Medical Centre, Monash University, and Monash Infectious Diseases, Monash Health, Clayton, Vic., Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>School of Clinical Sciences, Monash Medical Centre, Monash University, and Monash Infectious Diseases, Monash Health, Clayton, Vic.</wicri:regionArea></affiliation></author><author><name sortKey="Seifert, H" sort="Seifert, H" uniqKey="Seifert H" first="H" last="Seifert">H. Seifert</name><affiliation wicri:level="1"><nlm:affiliation>German Centre for Infection Research (DZIF), Braunschweig, Germany; Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, Cologne, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>German Centre for Infection Research (DZIF), Braunschweig, Germany; Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, Cologne</wicri:regionArea></affiliation></author><author><name sortKey="Thamlikitkul, V" sort="Thamlikitkul, V" uniqKey="Thamlikitkul V" first="V" last="Thamlikitkul">V. Thamlikitkul</name><affiliation wicri:level="1"><nlm:affiliation>Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</nlm:affiliation><country xml:lang="fr">Thaïlande</country><wicri:regionArea>Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok</wicri:regionArea></affiliation></author><author><name sortKey="Thwaites, G" sort="Thwaites, G" uniqKey="Thwaites G" first="G" last="Thwaites">G. Thwaites</name><affiliation wicri:level="1"><nlm:affiliation>Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam; Nuffield Department of Medicine, University of Oxford, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam; Nuffield Department of Medicine, University of Oxford</wicri:regionArea></affiliation></author><author><name sortKey="Tong, S Y C" sort="Tong, S Y C" uniqKey="Tong S" first="S Y C" last="Tong">S Y C. Tong</name><affiliation wicri:level="1"><nlm:affiliation>Global and Tropical Health Division, Menzies School of Health Research, Darwin, NT, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Global and Tropical Health Division, Menzies School of Health Research, Darwin, NT</wicri:regionArea></affiliation></author><author><name sortKey="Turnidge, J" sort="Turnidge, J" uniqKey="Turnidge J" first="J" last="Turnidge">J. Turnidge</name><affiliation wicri:level="1"><nlm:affiliation>Pathology, Paediatrics and Molecular Biosciences, University of Adelaide, SA, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Pathology, Paediatrics and Molecular Biosciences, University of Adelaide, SA</wicri:regionArea></affiliation></author><author><name sortKey="Utili, R" sort="Utili, R" uniqKey="Utili R" first="R" last="Utili">R. Utili</name><affiliation wicri:level="1"><nlm:affiliation>Internal Medicine, Second University of Naples, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Internal Medicine, Second University of Naples</wicri:regionArea></affiliation></author><author><name sortKey="Webb, S A R" sort="Webb, S A R" uniqKey="Webb S" first="S A R" last="Webb">S A R. Webb</name><affiliation wicri:level="1"><nlm:affiliation>Royal Perth Hospital, and School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Royal Perth Hospital, and School of Medicine and Pharmacology, University of Western Australia, Perth, WA</wicri:regionArea></affiliation></author><author><name sortKey="Paterson, D L" sort="Paterson, D L" uniqKey="Paterson D" first="D L" last="Paterson">D L Paterson</name><affiliation wicri:level="1"><nlm:affiliation>University of Queensland, UQ Centre for Clinical Research, Brisbane, Qld, Australia; Wesley Medical Research, Wesley Hospital, Toowong, Qld, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>University of Queensland, UQ Centre for Clinical Research, Brisbane, Qld, Australia; Wesley Medical Research, Wesley Hospital, Toowong, Qld</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:27810466</idno><idno type="pmid">27810466</idno><idno type="doi">10.1016/j.cmi.2016.10.023</idno><idno type="wicri:Area/PubMed/Corpus">000756</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000756</idno><idno type="wicri:Area/PubMed/Curation">000753</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000753</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Proposed primary endpoints for use in clinical trials that compare treatment options for bloodstream infection in adults: a consensus definition.</title><author><name sortKey="Harris, P N A" sort="Harris, P N A" uniqKey="Harris P" first="P N A" last="Harris">P N A. Harris</name><affiliation wicri:level="1"><nlm:affiliation>University of Queensland, UQ Centre for Clinical Research, Brisbane, Qld, Australia; Department of Microbiology, Pathology Queensland, Central Laboratory, Royal Brisbane & Women's Hospital, Brisbane, Qld, Australia. Electronic address: p.harris@uq.edu.au.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>University of Queensland, UQ Centre for Clinical Research, Brisbane, Qld, Australia; Department of Microbiology, Pathology Queensland, Central Laboratory, Royal Brisbane & Women's Hospital, Brisbane, Qld</wicri:regionArea></affiliation></author><author><name sortKey="Mcnamara, J F" sort="Mcnamara, J F" uniqKey="Mcnamara J" first="J F" last="Mcnamara">J F Mcnamara</name><affiliation wicri:level="1"><nlm:affiliation>University of Queensland, UQ Centre for Clinical Research, Brisbane, Qld, Australia; Department of Microbiology, Pathology Queensland, Central Laboratory, Royal Brisbane & Women's Hospital, Brisbane, Qld, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>University of Queensland, UQ Centre for Clinical Research, Brisbane, Qld, Australia; Department of Microbiology, Pathology Queensland, Central Laboratory, Royal Brisbane & Women's Hospital, Brisbane, Qld</wicri:regionArea></affiliation></author><author><name sortKey="Lye, D C" sort="Lye, D C" uniqKey="Lye D" first="D C" last="Lye">D C Lye</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Infectious Disease and Epidemiology, Tan Tock Seng Hospital and Yong Loo Lin School of Medicine, Singapore.</nlm:affiliation><country xml:lang="fr">Singapour</country><wicri:regionArea>Institute of Infectious Disease and Epidemiology, Tan Tock Seng Hospital and Yong Loo Lin School of Medicine</wicri:regionArea></affiliation></author><author><name sortKey="Davis, J S" sort="Davis, J S" uniqKey="Davis J" first="J S" last="Davis">J S Davis</name><affiliation wicri:level="1"><nlm:affiliation>Global and Tropical Health Division, Menzies School of Health Research, Darwin, NT, Australia; Department of Infectious Diseases, John Hunter Hospital, Newcastle, NSW, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Global and Tropical Health Division, Menzies School of Health Research, Darwin, NT, Australia; Department of Infectious Diseases, John Hunter Hospital, Newcastle, NSW</wicri:regionArea></affiliation></author><author><name sortKey="Bernard, L" sort="Bernard, L" uniqKey="Bernard L" first="L" last="Bernard">L. Bernard</name><affiliation wicri:level="1"><nlm:affiliation>Infectious Diseases Unit, Tours University Hospital, Tours, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Infectious Diseases Unit, Tours University Hospital, Tours</wicri:regionArea></affiliation></author><author><name sortKey="Cheng, A C" sort="Cheng, A C" uniqKey="Cheng A" first="A C" last="Cheng">A C Cheng</name><affiliation wicri:level="1"><nlm:affiliation>Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Vic., Australia; Department of Infectious Diseases, The Alfred Hospital and Central Clinical School, Monash University, Melbourne, Vic., Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Vic., Australia; Department of Infectious Diseases, The Alfred Hospital and Central Clinical School, Monash University, Melbourne, Vic.</wicri:regionArea></affiliation></author><author><name sortKey="Doi, Y" sort="Doi, Y" uniqKey="Doi Y" first="Y" last="Doi">Y. Doi</name><affiliation wicri:level="1"><nlm:affiliation>Division of Infectious Diseases, University of Pittsburgh School of Medicine, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Infectious Diseases, University of Pittsburgh School of Medicine, PA</wicri:regionArea></affiliation></author><author><name sortKey="Fowler, V G" sort="Fowler, V G" uniqKey="Fowler V" first="V G" last="Fowler">V G Fowler</name><affiliation wicri:level="1"><nlm:affiliation>Duke University Medical Center and Duke Clinical Research Institute, Durham, NC, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Duke University Medical Center and Duke Clinical Research Institute, Durham, NC</wicri:regionArea></affiliation></author><author><name sortKey="Kaye, K S" sort="Kaye, K S" uniqKey="Kaye K" first="K S" last="Kaye">K S Kaye</name><affiliation wicri:level="1"><nlm:affiliation>Wayne State University School of Medicine, Detroit Medical Center, Detroit, MI, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Wayne State University School of Medicine, Detroit Medical Center, Detroit, MI</wicri:regionArea></affiliation></author><author><name sortKey="Leibovici, L" sort="Leibovici, L" uniqKey="Leibovici L" first="L" last="Leibovici">L. Leibovici</name><affiliation wicri:level="1"><nlm:affiliation>Department of Medicine E, Beilinson Hospital, Rabin Medical Center, Petah-Tiqva, Israel; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.</nlm:affiliation><country xml:lang="fr">Israël</country><wicri:regionArea>Department of Medicine E, Beilinson Hospital, Rabin Medical Center, Petah-Tiqva, Israel; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv</wicri:regionArea></affiliation></author><author><name sortKey="Lipman, J" sort="Lipman, J" uniqKey="Lipman J" first="J" last="Lipman">J. Lipman</name><affiliation wicri:level="1"><nlm:affiliation>Burns, Trauma and Critical Care Research Centre, The University of Queensland, Brisbane, Qld, Australia; Department of Intensive Care Medicine, Royal Brisbane and Women's Hospital, Brisbane, Qld, Australia; The University of Witwatersrand, Johannesburg, South Africa.</nlm:affiliation><country xml:lang="fr">Afrique du Sud</country><wicri:regionArea>Burns, Trauma and Critical Care Research Centre, The University of Queensland, Brisbane, Qld, Australia; Department of Intensive Care Medicine, Royal Brisbane and Women's Hospital, Brisbane, Qld, Australia; The University of Witwatersrand, Johannesburg</wicri:regionArea></affiliation></author><author><name sortKey="Llewelyn, M J" sort="Llewelyn, M J" uniqKey="Llewelyn M" first="M J" last="Llewelyn">M J Llewelyn</name><affiliation wicri:level="1"><nlm:affiliation>Division of Medicine, Brighton and Sussex Medical School, Brighton, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Division of Medicine, Brighton and Sussex Medical School, Brighton</wicri:regionArea></affiliation></author><author><name sortKey="Munoz Price, S" sort="Munoz Price, S" uniqKey="Munoz Price S" first="S" last="Munoz-Price">S. Munoz-Price</name><affiliation wicri:level="1"><nlm:affiliation>Froedtert & Medical College of Wisconsin, Milwaukee, WI, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Froedtert & Medical College of Wisconsin, Milwaukee, WI</wicri:regionArea></affiliation></author><author><name sortKey="Paul, M" sort="Paul, M" uniqKey="Paul M" first="M" last="Paul">M. Paul</name><affiliation wicri:level="1"><nlm:affiliation>Division of Infectious Diseases, Rambam Health Care Campus and The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel.</nlm:affiliation><country xml:lang="fr">Israël</country><wicri:regionArea>Division of Infectious Diseases, Rambam Health Care Campus and The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa</wicri:regionArea></affiliation></author><author><name sortKey="Peleg, A Y" sort="Peleg, A Y" uniqKey="Peleg A" first="A Y" last="Peleg">A Y Peleg</name><affiliation wicri:level="1"><nlm:affiliation>Department of Microbiology, Monash University, Melbourne, Vic., Australia; School of Clinical Sciences, Monash Medical Centre, Monash University, and Monash Infectious Diseases, Monash Health, Clayton, Vic., Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Department of Microbiology, Monash University, Melbourne, Vic., Australia; School of Clinical Sciences, Monash Medical Centre, Monash University, and Monash Infectious Diseases, Monash Health, Clayton, Vic.</wicri:regionArea></affiliation></author><author><name sortKey="Rodriguez Ba O, J" sort="Rodriguez Ba O, J" uniqKey="Rodriguez Ba O J" first="J" last="Rodríguez-Ba O">J. Rodríguez-Ba O</name><affiliation wicri:level="1"><nlm:affiliation>Unidad Clínica Intercentros de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospitales Universitarios Virgen Macarena y Virgen del Rocío-IBiS and Departamento de Medicina, Universidad de Sevilla, Seville, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Unidad Clínica Intercentros de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospitales Universitarios Virgen Macarena y Virgen del Rocío-IBiS and Departamento de Medicina, Universidad de Sevilla, Seville</wicri:regionArea></affiliation></author><author><name sortKey="Rogers, B A" sort="Rogers, B A" uniqKey="Rogers B" first="B A" last="Rogers">B A Rogers</name><affiliation wicri:level="1"><nlm:affiliation>School of Clinical Sciences, Monash Medical Centre, Monash University, and Monash Infectious Diseases, Monash Health, Clayton, Vic., Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>School of Clinical Sciences, Monash Medical Centre, Monash University, and Monash Infectious Diseases, Monash Health, Clayton, Vic.</wicri:regionArea></affiliation></author><author><name sortKey="Seifert, H" sort="Seifert, H" uniqKey="Seifert H" first="H" last="Seifert">H. Seifert</name><affiliation wicri:level="1"><nlm:affiliation>German Centre for Infection Research (DZIF), Braunschweig, Germany; Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, Cologne, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>German Centre for Infection Research (DZIF), Braunschweig, Germany; Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, Cologne</wicri:regionArea></affiliation></author><author><name sortKey="Thamlikitkul, V" sort="Thamlikitkul, V" uniqKey="Thamlikitkul V" first="V" last="Thamlikitkul">V. Thamlikitkul</name><affiliation wicri:level="1"><nlm:affiliation>Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</nlm:affiliation><country xml:lang="fr">Thaïlande</country><wicri:regionArea>Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok</wicri:regionArea></affiliation></author><author><name sortKey="Thwaites, G" sort="Thwaites, G" uniqKey="Thwaites G" first="G" last="Thwaites">G. Thwaites</name><affiliation wicri:level="1"><nlm:affiliation>Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam; Nuffield Department of Medicine, University of Oxford, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam; Nuffield Department of Medicine, University of Oxford</wicri:regionArea></affiliation></author><author><name sortKey="Tong, S Y C" sort="Tong, S Y C" uniqKey="Tong S" first="S Y C" last="Tong">S Y C. Tong</name><affiliation wicri:level="1"><nlm:affiliation>Global and Tropical Health Division, Menzies School of Health Research, Darwin, NT, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Global and Tropical Health Division, Menzies School of Health Research, Darwin, NT</wicri:regionArea></affiliation></author><author><name sortKey="Turnidge, J" sort="Turnidge, J" uniqKey="Turnidge J" first="J" last="Turnidge">J. Turnidge</name><affiliation wicri:level="1"><nlm:affiliation>Pathology, Paediatrics and Molecular Biosciences, University of Adelaide, SA, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Pathology, Paediatrics and Molecular Biosciences, University of Adelaide, SA</wicri:regionArea></affiliation></author><author><name sortKey="Utili, R" sort="Utili, R" uniqKey="Utili R" first="R" last="Utili">R. Utili</name><affiliation wicri:level="1"><nlm:affiliation>Internal Medicine, Second University of Naples, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Internal Medicine, Second University of Naples</wicri:regionArea></affiliation></author><author><name sortKey="Webb, S A R" sort="Webb, S A R" uniqKey="Webb S" first="S A R" last="Webb">S A R. Webb</name><affiliation wicri:level="1"><nlm:affiliation>Royal Perth Hospital, and School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Royal Perth Hospital, and School of Medicine and Pharmacology, University of Western Australia, Perth, WA</wicri:regionArea></affiliation></author><author><name sortKey="Paterson, D L" sort="Paterson, D L" uniqKey="Paterson D" first="D L" last="Paterson">D L Paterson</name><affiliation wicri:level="1"><nlm:affiliation>University of Queensland, UQ Centre for Clinical Research, Brisbane, Qld, Australia; Wesley Medical Research, Wesley Hospital, Toowong, Qld, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>University of Queensland, UQ Centre for Clinical Research, Brisbane, Qld, Australia; Wesley Medical Research, Wesley Hospital, Toowong, Qld</wicri:regionArea></affiliation></author></analytic><series><title level="j">Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</title><idno type="eISSN">1469-0691</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">To define standardized endpoints to aid the design of trials that compare antibiotic therapies for bloodstream infections (BSI).</div></front></TEI><pubmed><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">27810466</PMID><DateCreated><Year>2016</Year><Month>11</Month><Day>04</Day></DateCreated><DateRevised><Year>2017</Year><Month>08</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1469-0691</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>8</Issue><PubDate><Year>2017</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</Title><ISOAbbreviation>Clin. Microbiol. Infect.</ISOAbbreviation></Journal><ArticleTitle>Proposed primary endpoints for use in clinical trials that compare treatment options for bloodstream infection in adults: a consensus definition.</ArticleTitle><Pagination><MedlinePgn>533-541</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1198-743X(16)30512-2</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cmi.2016.10.023</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To define standardized endpoints to aid the design of trials that compare antibiotic therapies for bloodstream infections (BSI).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Prospective studies, randomized trials or registered protocols comparing antibiotic therapies for BSI, published from 2005 to 2016, were reviewed. Consensus endpoints for BSI studies were defined using a modified Delphi process.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Different primary and secondary endpoints were defined for pilot (small-scale studies designed to evaluate protocol design, feasibility and implementation) and definitive trials (larger-scale studies designed to test hypotheses and influence clinical practice), as well as for Staphylococcus aureus and Gram-negative BSI. For pilot studies of S. aureus BSI, a primary outcome of success at day 7 was defined by: survival, resolution of fever, stable/improved Sequential Organ Failure Assessment (SOFA) score and clearance of blood cultures, with no microbiologically confirmed failure up to 90 days. For definitive S. aureus BSI studies, a primary outcome of success at 90 days was defined by survival and no microbiologically confirmed failure. For pilot studies of Gram-negative BSI, a primary outcome of success at day 7 was defined by: survival, resolution of fever and symptoms related to BSI source, stable or improved SOFA score and negative blood cultures. For definitive Gram-negative BSI studies, a primary outcome of survival at 90 days supported by a secondary outcome of success at day 7 (as previously defined) was agreed.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These endpoints provide a framework to aid future trial design. Further work will be required to validate these endpoints with respect to patient-centred clinical outcomes.</AbstractText><CopyrightInformation>Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Harris</LastName><ForeName>P N A</ForeName><Initials>PNA</Initials><AffiliationInfo><Affiliation>University of Queensland, UQ Centre for Clinical Research, Brisbane, Qld, Australia; Department of Microbiology, Pathology Queensland, Central Laboratory, Royal Brisbane & Women's Hospital, Brisbane, Qld, Australia. Electronic address: p.harris@uq.edu.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McNamara</LastName><ForeName>J F</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>University of Queensland, UQ Centre for Clinical Research, Brisbane, Qld, Australia; Department of Microbiology, Pathology Queensland, Central Laboratory, Royal Brisbane & Women's Hospital, Brisbane, Qld, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lye</LastName><ForeName>D C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Institute of Infectious Disease and Epidemiology, Tan Tock Seng Hospital and Yong Loo Lin School of Medicine, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davis</LastName><ForeName>J S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Global and Tropical Health Division, Menzies School of Health Research, Darwin, NT, Australia; Department of Infectious Diseases, John Hunter Hospital, Newcastle, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernard</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Infectious Diseases Unit, Tours University Hospital, Tours, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>A C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Vic., Australia; Department of Infectious Diseases, The Alfred Hospital and Central Clinical School, Monash University, Melbourne, Vic., Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doi</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, University of Pittsburgh School of Medicine, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fowler</LastName><ForeName>V G</ForeName><Initials>VG</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Duke University Medical Center and Duke Clinical Research Institute, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaye</LastName><ForeName>K S</ForeName><Initials>KS</Initials><AffiliationInfo><Affiliation>Wayne State University School of Medicine, Detroit Medical Center, Detroit, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leibovici</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medicine E, Beilinson Hospital, Rabin Medical Center, Petah-Tiqva, Israel; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lipman</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Burns, Trauma and Critical Care Research Centre, The University of Queensland, Brisbane, Qld, Australia; Department of Intensive Care Medicine, Royal Brisbane and Women's Hospital, Brisbane, Qld, Australia; The University of Witwatersrand, Johannesburg, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Llewelyn</LastName><ForeName>M J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Division of Medicine, Brighton and Sussex Medical School, Brighton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Munoz-Price</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Froedtert & Medical College of Wisconsin, Milwaukee, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paul</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Rambam Health Care Campus and The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peleg</LastName><ForeName>A Y</ForeName><Initials>AY</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Monash University, Melbourne, Vic., Australia; School of Clinical Sciences, Monash Medical Centre, Monash University, and Monash Infectious Diseases, Monash Health, Clayton, Vic., Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodríguez-Baño</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Unidad Clínica Intercentros de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospitales Universitarios Virgen Macarena y Virgen del Rocío-IBiS and Departamento de Medicina, Universidad de Sevilla, Seville, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rogers</LastName><ForeName>B A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>School of Clinical Sciences, Monash Medical Centre, Monash University, and Monash Infectious Diseases, Monash Health, Clayton, Vic., Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seifert</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>German Centre for Infection Research (DZIF), Braunschweig, Germany; Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, Cologne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thamlikitkul</LastName><ForeName>V</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thwaites</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam; Nuffield Department of Medicine, University of Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tong</LastName><ForeName>S Y C</ForeName><Initials>SYC</Initials><AffiliationInfo><Affiliation>Global and Tropical Health Division, Menzies School of Health Research, Darwin, NT, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turnidge</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Pathology, Paediatrics and Molecular Biosciences, University of Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Utili</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Internal Medicine, Second University of Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Webb</LastName><ForeName>S A R</ForeName><Initials>SAR</Initials><AffiliationInfo><Affiliation>Royal Perth Hospital, and School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paterson</LastName><ForeName>D L</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>University of Queensland, UQ Centre for Clinical Research, Brisbane, Qld, Australia; Wesley Medical Research, Wesley Hospital, Toowong, Qld, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>11</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin Microbiol Infect</MedlineTA><NlmUniqueID>9516420</NlmUniqueID><ISSNLinking>1198-743X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antibiotic therapy</Keyword><Keyword MajorTopicYN="N">Bacteraemia</Keyword><Keyword MajorTopicYN="N">Bacterial infections</Keyword><Keyword MajorTopicYN="N">Clinical trials</Keyword><Keyword MajorTopicYN="N">Treatment outcome</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>08</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>10</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>10</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27810466</ArticleId><ArticleId IdType="pii">S1198-743X(16)30512-2</ArticleId><ArticleId IdType="doi">10.1016/j.cmi.2016.10.023</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000753 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000753 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:27810466
|texte= Proposed primary endpoints for use in clinical trials that compare treatment options for bloodstream infection in adults: a consensus definition.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:27810466" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |